111, Inc.
111, Inc is a Healthcare company operating in Medical Distribution with a $32.5M market cap.
Most recent earnings call: Q4 FY24 on Mar 20, 2025.
16 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks YI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for YI.
$ curl https://api.spokenalpha.com/v1/companies/YIFAQ
Spoken Alpha indexes YI's earnings call transcripts at https://spokenalpha.com/companies/YI. Each call links to attributed speakers and parsed analyst Q&A. 111, Inc.'s own investor relations page is at https://ir.111.com.cn/.
111, Inc. (YI) held its most recent earnings call on 2025-03-20, covering fiscal Q4 2024.
111, Inc. (YI) operates in the Healthcare sector (Medical Distribution industry).
Repeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2024 | $1.43 | $1.54 | -7.4% | -6.1% | -8.2% |
| Q4 FY2024 | $1.45 | $1.56 | -6.9% | -2.7% | -3.4% |
| Q3 FY2024 | $1.45 | $1.67 | -13.3% | +3.8% | +6.3% |
| Q2 FY2024 | $1.41 | $1.59 | -11.4% | -7.0% | -7.2% |
| Q1 FY2023 | $1.71 | $1.76 | -2.6% | -4.0% | -1.7% |
| Q4 FY2023 |
| $1.48 |
| $1.51 |
| -1.9% |
| +0.5% |
| +0.7% |
| Q3 FY2023 | $1.55 | $1.69 | -8.2% | -1.1% | -0.3% |
| Q2 FY2023 | $1.43 | $1.57 | -8.7% | -2.6% | -3.1% |
| Q1 FY2022 | $1.67 | $1.81 | -7.7% | -0.7% | -2.2% |
| Q4 FY2022 | $1.55 | $1.75 | -11.5% | +3.2% | +1.4% |